Summary of ORAMED PHARMACEUTICALS INC.

Search - Finance Home - Yahoo! - Help

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

ORMP.OB > SEC Filings for ORMP.OB > Form 8-K on 19-Aug-2009

All Recent SEC Filings

Show all filings for ORAMED PHARMACEUTICALS INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ORAMED PHARMACEUTICALS INC.

19-Aug-2009

Regulation FD Disclosure, Financial Statements and Exhibits

ITEM 7.01 REGULATION FD DISCLOSURE.

On August 18, 2009, Oramed Pharmaceuticals Inc. issued a press release announcing that its Chief Scientific Officer, Miriam Kidron, Ph.D. was chosen to lecture at the 2009 British Pharmaceutical Conference in Manchester, England on September 9, 2009.

A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

Exhibit Number Description

99.1 Press Release dated August 18, 2009

Add ORMP.OB to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for ORMP.OB - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.